WMO Education and Training Programme

Vaccine Development
The process of developing a vaccine is laborious and complex, taking more than ten years in every case. Vaccines can be used therapeutically or prophylactically. A therapeutic vaccination is always intended to prevent cancer, but a prophylactic vaccine is intended to stop a future infection by a naturally occurring disease. Vaccines are frequently natural pathogens that are dead or inactivated or pathogen analogs. Here, we provide a quick overview of the uses of exosomes in the creation of vaccines. In addition, Creative Biolabs provides a wide range of exosome-related services to support the development of vaccines and to further exosome research.
derived from cells Vaccines based on exosomes
Exosomes are vesicles derived from cells that can be produced by a variety of cell types, such as tumor, ascitic, and dendritic cells. To help with exosome research for the production of vaccines, Creative Biolabs provides clients with a comprehensive spectrum of exosome-related services.

Cell-derived exosome-based Vaccines

Exosomes generated from tumor cells express chemicals specific to tumors that are connected with membranes, which makes them a promising vaccination for cancer therapies by enhancing the immune system's ability to fight cancer.

Vaccines based on exosomes generated from ascitic cells

Tumor exosome origins in patients with ovarian cancer and some other cancers are ascitic fluids. Exosomes produced from ascitic cells may also contain antigens unique to tumors, making them a promising candidate for the development of novel vaccines.

vaccines made using exosomes generated from dendritic cells

Exosomes generated from dendritic cells carry costimulatory molecules, MHC I, and MHC II on their surface. When paired with synthetic peptides or intriguing pathogen epitopes, these exosomes can function as powerful vaccines.